Cargando…
The role of (18)F-FCH PET/CT in patients with uremic hyperparathyroidism compared with (99m)Tc-sestaMIBI SPECT/CT and ultrasonography
BACKGROUND: The aim of this study was to evaluate the diagnostic efficacy of (18)F-fluorocholine ((18)F-FCH) PET/CT for uremic hyperparathyroidism (uHPT) compared to (99m)Tc-sestaMIBI SPECT/CT and ultrasonography (US). METHODS: A total of 17 uHPT patients with stage 5 chronic kidney disease (CKD) we...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933043/ https://www.ncbi.nlm.nih.gov/pubmed/31879808 http://dx.doi.org/10.1186/s13550-019-0583-9 |
_version_ | 1783483133584211968 |
---|---|
author | Xue, Yu Li, Wenbo Xia, Zhu Lei, Chengming Cao, Yiyi Wang, Zhengjie Pang, Hua |
author_facet | Xue, Yu Li, Wenbo Xia, Zhu Lei, Chengming Cao, Yiyi Wang, Zhengjie Pang, Hua |
author_sort | Xue, Yu |
collection | PubMed |
description | BACKGROUND: The aim of this study was to evaluate the diagnostic efficacy of (18)F-fluorocholine ((18)F-FCH) PET/CT for uremic hyperparathyroidism (uHPT) compared to (99m)Tc-sestaMIBI SPECT/CT and ultrasonography (US). METHODS: A total of 17 uHPT patients with stage 5 chronic kidney disease (CKD) were prospectively enrolled. All patients underwent US, (99m)Tc-sestaMIBI SPECT/CT, and (18)F-FCH within 2 months and received surgical treatment. Visual and quantitative methods were used for image analyses. Intraoperative localization and postoperative histological results of the reference standard as well as the sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) of the three modalities were analyzed using Pearson’s χ(2) tests. In addition, the diagnostic efficacy of (18)F-FCH PET/CT for uHPT was evaluated. The relationships between PET parameters and laboratory parameters were assessed using the Spearman correlation coefficient. RESULTS: A total of 63 parathyroid hyperplasia lesions were resected in 17 uHPT patients, and 53 lesions were detected using (18)F-FCH PET/CT with no false-positive results. The sensitivity, specificity, accuracy, PPV, and NPV were 84.13%, 100%, 86.49%, 100%, and 52.38%, respectively. In comparison, the corresponding values for (99m)Tc-sestaMIBI SPECT/CT and US were 63.49%, 90.91%, 67.57%, 97.56%, and 30.30% and 61.90%, 81.82%, 64.86%, 95.12%, and 27.27%, respectively. The volume of hyper-functioning parathyroid glands was significantly different between lesions positive in (18)F-FCH PET/CT and negative in (18)F-FCH PET/CT (mean volume 1.36 ± 0.55 cm(3) vs. 0.83 ± 0.26 cm(3); P = 0.019). US misidentified intrathyroidal parathyroid hyperplasia as thyroid nodules in three patients, while (18)F-FCH PET correctly identified the anatomy. No significant associations were observed between PET parameters and laboratory parameters in uHPT. CONCLUSION: (18)F-FCH PET/CT was more sensitive and accurate for uHPT than (99m)Tc-sestaMIBI SPECT/CT and US, and had better preoperative diagnostic efficacy, particularly for lesions diagnosed as a thyroid nodule by US. |
format | Online Article Text |
id | pubmed-6933043 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-69330432020-01-09 The role of (18)F-FCH PET/CT in patients with uremic hyperparathyroidism compared with (99m)Tc-sestaMIBI SPECT/CT and ultrasonography Xue, Yu Li, Wenbo Xia, Zhu Lei, Chengming Cao, Yiyi Wang, Zhengjie Pang, Hua EJNMMI Res Original Research BACKGROUND: The aim of this study was to evaluate the diagnostic efficacy of (18)F-fluorocholine ((18)F-FCH) PET/CT for uremic hyperparathyroidism (uHPT) compared to (99m)Tc-sestaMIBI SPECT/CT and ultrasonography (US). METHODS: A total of 17 uHPT patients with stage 5 chronic kidney disease (CKD) were prospectively enrolled. All patients underwent US, (99m)Tc-sestaMIBI SPECT/CT, and (18)F-FCH within 2 months and received surgical treatment. Visual and quantitative methods were used for image analyses. Intraoperative localization and postoperative histological results of the reference standard as well as the sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) of the three modalities were analyzed using Pearson’s χ(2) tests. In addition, the diagnostic efficacy of (18)F-FCH PET/CT for uHPT was evaluated. The relationships between PET parameters and laboratory parameters were assessed using the Spearman correlation coefficient. RESULTS: A total of 63 parathyroid hyperplasia lesions were resected in 17 uHPT patients, and 53 lesions were detected using (18)F-FCH PET/CT with no false-positive results. The sensitivity, specificity, accuracy, PPV, and NPV were 84.13%, 100%, 86.49%, 100%, and 52.38%, respectively. In comparison, the corresponding values for (99m)Tc-sestaMIBI SPECT/CT and US were 63.49%, 90.91%, 67.57%, 97.56%, and 30.30% and 61.90%, 81.82%, 64.86%, 95.12%, and 27.27%, respectively. The volume of hyper-functioning parathyroid glands was significantly different between lesions positive in (18)F-FCH PET/CT and negative in (18)F-FCH PET/CT (mean volume 1.36 ± 0.55 cm(3) vs. 0.83 ± 0.26 cm(3); P = 0.019). US misidentified intrathyroidal parathyroid hyperplasia as thyroid nodules in three patients, while (18)F-FCH PET correctly identified the anatomy. No significant associations were observed between PET parameters and laboratory parameters in uHPT. CONCLUSION: (18)F-FCH PET/CT was more sensitive and accurate for uHPT than (99m)Tc-sestaMIBI SPECT/CT and US, and had better preoperative diagnostic efficacy, particularly for lesions diagnosed as a thyroid nodule by US. Springer Berlin Heidelberg 2019-12-26 /pmc/articles/PMC6933043/ /pubmed/31879808 http://dx.doi.org/10.1186/s13550-019-0583-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Research Xue, Yu Li, Wenbo Xia, Zhu Lei, Chengming Cao, Yiyi Wang, Zhengjie Pang, Hua The role of (18)F-FCH PET/CT in patients with uremic hyperparathyroidism compared with (99m)Tc-sestaMIBI SPECT/CT and ultrasonography |
title | The role of (18)F-FCH PET/CT in patients with uremic hyperparathyroidism compared with (99m)Tc-sestaMIBI SPECT/CT and ultrasonography |
title_full | The role of (18)F-FCH PET/CT in patients with uremic hyperparathyroidism compared with (99m)Tc-sestaMIBI SPECT/CT and ultrasonography |
title_fullStr | The role of (18)F-FCH PET/CT in patients with uremic hyperparathyroidism compared with (99m)Tc-sestaMIBI SPECT/CT and ultrasonography |
title_full_unstemmed | The role of (18)F-FCH PET/CT in patients with uremic hyperparathyroidism compared with (99m)Tc-sestaMIBI SPECT/CT and ultrasonography |
title_short | The role of (18)F-FCH PET/CT in patients with uremic hyperparathyroidism compared with (99m)Tc-sestaMIBI SPECT/CT and ultrasonography |
title_sort | role of (18)f-fch pet/ct in patients with uremic hyperparathyroidism compared with (99m)tc-sestamibi spect/ct and ultrasonography |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933043/ https://www.ncbi.nlm.nih.gov/pubmed/31879808 http://dx.doi.org/10.1186/s13550-019-0583-9 |
work_keys_str_mv | AT xueyu theroleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography AT liwenbo theroleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography AT xiazhu theroleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography AT leichengming theroleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography AT caoyiyi theroleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography AT wangzhengjie theroleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography AT panghua theroleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography AT xueyu roleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography AT liwenbo roleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography AT xiazhu roleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography AT leichengming roleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography AT caoyiyi roleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography AT wangzhengjie roleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography AT panghua roleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography |